MET-TEST is a leader in providing patient-specific, data-driven technology using state-of-the-art analytical tools, trained specialists, and powerful proprietary AI pattern recognition software that enable healthcare organizations to optimize medication regimens and improve patient outcomes. This results in reduced hospitalizations, lower healthcare costs, and improved risk management. 

Since inception in 2003, MET-TEST has been providing pulmonary function testing (PFT) and cardiopulmonary exercise testing (CPET) as a standard and centralized service to community-based clinics and hospitals. We have tested over 230,000 patients and in the process, have accumulated real world clinical expertise that we share with our partner sites to improve patient management.

We are a privately held corporation headquartered in Atlanta, Georgia. USA

Cardiopulmonary Exercise Test (CPET) is the only non-invasive exercise stress test that assesses heart and lung function in real-time during exercise. Your heart and lungs work together to deliver oxygen to your working muscles where it is used to make energy; and to remove carbon dioxide from the body. CPET measures the amount of oxygen your body is using, the amount of carbon dioxide it is producing, your breathing pattern, and electrocardiogram (EKG) while you are riding a stationary bicycle.  

This data undergoes expert analysis in the data center where exercise capacity is quantified using MET-TEST powerful proprietary AI pattern recognition software, and the mechanism of patient symptoms is prioritized.

A typical stress test involves walking on a treadmill while your heart rate and blood pressure are monitored. By starting at a slow speed, doctors can slowly increase the speed of the treadmill to induce stress and see how an individual’s heart reacts. The test’s EKG readout is supposed to indicate if there’s a cardiovascular issue present, but in a lot of instances, it doesn’t.

“If you pick something up on the EKG, then you have a problem and you need to look at it,” said Dr. Chaudhry. “Most of the time, you’re not going to pick anything up. Unless you fall over and have a heart attack, it’s not going to really tell you much.”

But the vast majority of treadmill tests are found to be deceptively normal. Of the few that are reported as abnormal, further evaluation and treatment will include invasive, unnecessary and expensive procedures. Research over the last 20 years has shown that such procedures in asymptomatic individuals do not improve their clinical outcomes.

MET-TEST, however, works to shift the focus from diagnosing developed heart disease to preventing it. MET-TEST’s CPET is able to detect and track heart disease and cardiac dysfunction in its earliest stages.

“This way, we can help patients avoid those unnecessary procedures and make sure all of the ‘false-normal’ tests don’t become future problems,” said Dr. Chaudhry.

Through a combination of the earliest detection with aggressive risk factor management, MET-TEST successfully decreases hospitalizations, ineffective and invasive procedures, and subsequent healthcare costs.

With progression of coronary disease, peak cardiac function (Peak VO2) will deteriorate, so serial CPET testing serves as a key tool to help monitor changes in cardiac health over time. Improvements can be seen within six months of implementing lifestyle and medical therapies, but at the very minimum, patients with an abnormal CPET should have one done annually to follow the course of their disease and confirm response to therapeutic interventions.

Patients started on beta-blocker medication may need to repeat their test in one month to determine the most effective dosage for optimizing cardiac function (since this will vary among individuals).

The goal in every person is to increase Peak VO2 from baseline by 10% or more per test until the underlying cardiac dysfunction pattern is completely normalized as seen in the case study. Click here for details

Nuclear stress test is an imaging method that uses radioactive material to show how well blood flows into the heart muscle, both at rest and during activity. A radiotracer is injected into a peripheral vein. As the radiotracer decays, gamma radiation is emitted and is detected by a Gamma camera. A nuclear stress test may be inaccurate if someone has severe blockages in all three main coronary arteries. 

A nuclear stress test, also known as a cardiac stress test or Thallium, is not usually able to detect blockages that are less than 70% of the heart's arteries

A nuclear stress test can't detect blockages that don't impact blood flow to the heart muscle. It also can't identify where blood flow is affected. 

An abnormal nuclear stress test result usually means that the patient has more than 70% blockage in their coronary arteries. A coronary arteriogram is the only way to know for sure if there are blockages in the heart. 

During a traditional treadmill stress test the patient walks on the treadmill as it gets faster and steeper. The blood pressure and electrocardiogram (EKG) are the only aspects of the cardiovascular system that are measured during this test.

Doctors primarily look at a specific part of the EKG to determine if there are blockages in the large blood vessels of the heart (coronary artery disease) preventing it from getting enough oxygen (ischemia is the condition when the heart is not getting enough oxygen). However, in many people with heart disease, this EKG abnormality never appears. Additionally, the body motion of walking often causes the EKG signal to have artifact and become unclear to read.

A treadmill stress test is generally not sensitive enough to detect blockages in the coronary arteries that are less than 50%. It is most effective at identifying significant blockages, usually considered to be around 70% or greater, where blood flow is significantly restricted during exercise. 

Stress tests can effectively show whether the heart's arteries are 70% blockage narrowed or more. But heart attacks can arise from arteries that are less than 50 percent blocked.

MET-TEST CPET stress test, however, works to shift the focus from diagnosing developed heart disease to preventing it. MET-TEST’s CPET is able to detect before 70% and track heart disease and cardiac dysfunction in its earliest stages.

Adesso and MET-TEST Empowering Women Worldwide.

A woman dies about once every minute from heart disease. Though most women aren’t aware of it, cardiovascular disease is the number 1 killer of women, causing 1 in 3 deaths each year. Despite this fact, only about half (44%) of women recognize that heart disease is their number 1 killer. 

Heart disease in women has been routinely misdiagnosed and undertreated, because of unconscious bias that suggested heart disease was a “man’s disease.” Adesso was launched to empower women to live healthy, vital lives through comprehensive heart-centered prevention and wellness.

We’ve tailored our program for busy women. MyAdesso is not just another check on a to-do list, but an introduction to a community and support to help you live with vitality. MyAdesso is “me time” that will save your life.

Over the last decade, our understanding of women’s heart disease has improved exponentially, and it has become apparent that heart disease affects men and women in different ways. Here are some facts about heart disease in women: 

• Heart disease is the number #1 cause of death in women 
• 1 in 3 women will die of a heart attack or stroke
• Heart disease causes more deaths in women than all forms of cancer combined
• Two-thirds of women with heart disease report no symptoms prior to a heart attack
• Almost half of African-American women over the age of 20 have heart disease
• 90% of all women have 1 or more risk factors for heart disease and stroke

Click here for more Information on Women's Health

Sudden cardiac death accounts for approximately half of all on-duty death among firefighters

Firefighting work demands can be extreme and an accurate assessment of cardiopulmonary status, as well as detection and treatment of any underlying cardiovascular disease, is critical to ensured firefighter fitness for duty and prevent on-duty cardiac events or death. Exercise stress testing serves two primary purposes in assessing firefighter safety; evaluation of cardiorespiratory fitness and detection of under-treated cardiovascular disease. Cardiopumonary Exercise Testing (CPET) has made significant advances in the last decade and is superior to the traditional Treadmill stress test (Treadmill vs. CPET). To accomplish these goals upgrade to MET-TEST. 

Are you getting the most out of your annual stress test? 

Consider ditching the treadmill and implementing this three-step program.  By FireRescue1 BrandFocus Staff

RESPIRATORY LIMITATIONS?

MET-TEST offers comprehensive respiratory evaluations through advanced Pulmonary Function Testing (PFT). 

MET-TEST’s Pulmonary Function Test assesses how well your lungs are functioning by measuring lung volume, capacity, air flow, and gas exchange. It is performed by an experienced exercise physiologist. The total time required to perform this test is about 30 minutes. Comprehensive Pulmonary Function Testing provides objective and quantitative data to substantiate injury claims.

MET-TEST provides accurate PFT results through quality control measures, thus ruling out poor patient effort.

MET-TEST has been selected by a renowned multi-state legal firm for its expertise in Pulmonary Function Tests. MET-TEST’s Pulmonary Function Test has supported product liability claims for mesothelioma and asbestos. MET-TEST has tested over 17,000 victims of asbestos in multiple states.

CAUSES OF ABNORMAL PULMONARY FUNCTION:

- Asbestos

- Asthma

- Cancer

- Chemical Exposure

- Chronic Obstructive

- Pulmonary Disease (COPD)

- Environmental Toxins

- Heart Failure

- Long-COVID

- Lung Injury

- Mold Inhalation

- Pulmonary Infection

- Smoke Inhalation

- Solvent Exposure

High-risk Industries for developing Lung Disease:

- Automotive Repair

- Construction

- Food Industry

- Farming

- Manufacturing

- Mining

- Warehouse Distribution

THE MET-TEST ADVANTAGE

- Standardized Testing

- Accurate and Reproducible

- Baseline Comparison and Long-Term Tracking

For more information, see attached brochure